These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 25499970

  • 1. Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α.
    Gao H, Xie J, Peng J, Han Y, Jiang Q, Han M, Wang C.
    Exp Cell Res; 2015 Mar 15; 332(2):236-46. PubMed ID: 25499970
    [Abstract] [Full Text] [Related]

  • 2. Cordycepin down-regulates multiple drug resistant (MDR)/HIF-1α through regulating AMPK/mTORC1 signaling in GBC-SD gallbladder cancer cells.
    Wu WD, Hu ZM, Shang MJ, Zhao DJ, Zhang CW, Hong DF, Huang DS.
    Int J Mol Sci; 2014 Jul 18; 15(7):12778-90. PubMed ID: 25046749
    [Abstract] [Full Text] [Related]

  • 3. Oridonin inhibits hypoxia-induced epithelial-mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer.
    Chen K, Ye J, Qi L, Liao Y, Li R, Song S, Zhou C, Feng R, Zhai W.
    Anticancer Drugs; 2019 Oct 18; 30(9):925-932. PubMed ID: 31517732
    [Abstract] [Full Text] [Related]

  • 4. MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer.
    He M, Zhan M, Chen W, Xu S, Long M, Shen H, Shi Y, Liu Q, Mohan M, Wang J.
    Cell Physiol Biochem; 2017 Oct 18; 42(5):2078-2092. PubMed ID: 28803245
    [Abstract] [Full Text] [Related]

  • 5. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM, Padgaonkar AA, Jalota-Badhwar A, Rao SV, Joshi KS.
    Prostate Cancer Prostatic Dis; 2012 Mar 18; 15(1):15-27. PubMed ID: 22083267
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dictamnine promotes apoptosis and inhibits epithelial-mesenchymal transition, migration, invasion and proliferation by downregulating the HIF-1α and Slug signaling pathways.
    Wang JY, Wang Z, Li MY, Zhang Z, Mi C, Zuo HX, Xing Y, Wu YL, Lian LH, Xu GH, Piao LX, Ma J, Jin X.
    Chem Biol Interact; 2018 Dec 25; 296():134-144. PubMed ID: 30266538
    [Abstract] [Full Text] [Related]

  • 8. Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells.
    Yu Y, Wang J, Xia N, Li B, Jiang X.
    Oncol Rep; 2015 Apr 25; 33(4):1683-90. PubMed ID: 25633045
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling.
    Li MY, Mi C, Wang KS, Wang Z, Zuo HX, Piao LX, Xu GH, Li X, Ma J, Jin X.
    Chem Biol Interact; 2017 Aug 25; 274():58-67. PubMed ID: 28684144
    [Abstract] [Full Text] [Related]

  • 13. Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer.
    Kawamoto M, Onishi H, Ozono K, Yamasaki A, Imaizumi A, Kamakura S, Nakano K, Oda Y, Sumimoto H, Nakamura M.
    Oncotarget; 2017 May 30; 8(22):36211-36224. PubMed ID: 28423707
    [Abstract] [Full Text] [Related]

  • 14. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
    Wang H, Zhang C, Xu L, Zang K, Ning Z, Jiang F, Chi H, Zhu X, Meng Z.
    Oncotarget; 2016 Apr 12; 7(15):20193-208. PubMed ID: 26958938
    [Abstract] [Full Text] [Related]

  • 15. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
    Xu H, Zhao L, Fang Q, Sun J, Zhang S, Zhan C, Liu S, Zhang Y.
    PLoS One; 2014 Apr 12; 9(12):e115565. PubMed ID: 25531114
    [Abstract] [Full Text] [Related]

  • 16. Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB.
    Zhang DC, Liu JL, Ding YB, Xia JG, Chen GY.
    Acta Pharmacol Sin; 2013 Feb 12; 34(2):301-8. PubMed ID: 23274410
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway.
    Zhang F, Li M, Wu X, Hu Y, Cao Y, Wang X, Xiang S, Li H, Jiang L, Tan Z, Lu W, Weng H, Shu Y, Gong W, Wang X, Zhang Y, Shi W, Dong P, Gu J, Liu Y.
    Drug Des Devel Ther; 2015 Feb 12; 9():3969-87. PubMed ID: 26309394
    [Abstract] [Full Text] [Related]

  • 19. Hispidulin potentiates the antitumor effect of sunitinib against human renal cell carcinoma in laboratory models.
    Gao H, Jiang Q, Han Y, Peng J, Wang C.
    Cell Biochem Biophys; 2015 Mar 12; 71(2):757-64. PubMed ID: 25260394
    [Abstract] [Full Text] [Related]

  • 20. Bufalin inhibits ovarian carcinoma via targeting mTOR/HIF-α pathway.
    Su S, Dou H, Wang Z, Zhang Q.
    Basic Clin Pharmacol Toxicol; 2021 Feb 12; 128(2):224-233. PubMed ID: 32905663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.